TTNP...FDA Approves New Opioid Addiction Treatment Tech


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


Bloomberg reported Thursday that the FDA granted approval to Titan Pharmaceuticals Inc (NASDAQ: TTNP) and partner Braeburn Pharmaceuticals for the first implant in the U.S. for the treatment of addiction to heroin and opioid-based painkillers.

 

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

First to Market

 

The product, Probuphine, will hit the market just as Congress and the White House have been working together to tackle what is being called an “epidemic” of heroin and opioid painkiller abuse in the country. The implant will deliver to patients a drug known as buprenorphine, a less-addictive alternative to methadone for treating opioid addiction.

 

Playing Catch Up


Wall Street Vet Reveals $9 Options Secret

Tired of tiny stock gains? This 40-year insider is spilling the beans on how to turn small investments into 600% returns. Get his proven options strategy in a FREE webinar.—Register now – seats are limited!


 

Other biotech companies developing similar tools saw their shares declining in the wake of Titan’s regulatory triumph. British spin-off company Invidior PLC has an injectable in late-stage study, and BioDelivery Sciences International Inc (NASDAQ: BDSI) has an injectable in its product pipeline.

 

Shares of Invidior were down 0.4 percent today at $172.40 an hour into Friday’s trading.

 

BioDelivery Sciences, which already sells a form of buprenorphine, saw its shares rise just over 2 percent at $2.14 Friday morning.

 

Shares of Titan Pharmaceuticals rose 12.5 percent following the news Thursday, and were trading at 12-month highs Friday.


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


Posted In: BiotechLong IdeasHealth CareTrading IdeasGeneral